Bài phát biểu đầy đủ của Bitcoin 2025 Vance: Tài sản kỹ thuật số là biểu tượng và động lực cho quyền tự do cá nhân của người Mỹ

BioTrove

company

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$5.30M
Industries
Biotechnology,Genetics,Health Care,Life Science
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications. The company offers OpenArray, a technology platform for relative gene expression analysis that advances genomic research in various life science fields, including agriculture, disease research, and public health; RapidFire, a technology platform that enables the screening of intractable drug targets via mass spectrometry based assay development; and RapidFire mass spectrometry hardware system, a native detection technology for drug screening and in vitro ADME applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$28.20M
BioTrove has raised a total of $28.20M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2006 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2006 Series Unknown $7M 1 Detail
Jul 16, 2005 Series B $5M 1 Detail
Jan 29, 2004 Series B $10.90M 1 Detail
Oct 16, 2002 Private Equity(PE) $5.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
BioTrove is funded by 3 investors. Echelon Ventures and Biofrontier Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Echelon Ventures Series Unknown
Biofrontier Partners Series B
BioFrontier Partners Private Equity(PE)